KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Equity (2016 - 2025)

Historic Return on Equity for Bristol Myers Squibb (BMY) over the last 16 years, with Q3 2025 value amounting to 0.34%.

  • Bristol Myers Squibb's Return on Equity rose 7600.0% to 0.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 0.39% for FY2024, which is 6000.0% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Return on Equity stood at 0.34% for Q3 2025, which was up 7600.0% from 0.29% recorded in Q2 2025.
  • Bristol Myers Squibb's Return on Equity's 5-year high stood at 0.34% during Q3 2025, with a 5-year trough of 0.53% in Q4 2024.
  • For the 5-year period, Bristol Myers Squibb's Return on Equity averaged around 0.04%, with its median value being 0.17% (2021).
  • In the last 5 years, Bristol Myers Squibb's Return on Equity crashed by -8100bps in 2024 and then soared by 7600bps in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Return on Equity stood at 0.17% in 2021, then fell by -5bps to 0.16% in 2022, then surged by 69bps to 0.27% in 2023, then tumbled by -294bps to 0.53% in 2024, then surged by 163bps to 0.34% in 2025.
  • Its last three reported values are 0.34% in Q3 2025, 0.29% for Q2 2025, and 0.32% during Q1 2025.